Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation

被引：2
|
作者：
Castagna, L. [1 ]
Sarina, B. [1 ,8 ]
Crocchiolo, R. [1 ,4 ]
Bramanti, S. [4 ,5 ,7 ]
Furst, S. [3 ,4 ,6 ,8 ]
Devillier, R. [2 ,4 ,5 ,7 ]
Coso, D. [2 ,9 ]
Bouabdallah, R. [3 ,5 ]
Mokart, D. [6 ,8 ]
Morabito, L. [6 ]
Harbi, S. [2 ,8 ,9 ]
Giordano, L. [7 ]
Rimondo, A.
Weiller, P. Jean
Carlo-Stella, C. [9 ]
Santoro, A. [3 ]
Chabannon, C.
Blaise, D.
机构：
[1] Dept Hematol, Transplantat Program, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy
[2] Dept Hematol, Lymphoma Program, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy
[3] Inst Paoli Calmettes, Intens Care Unit, Marseille, France
[4] Biostatist Unit, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy
[5] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy
[6] Humanitas Univ, Rozzano, Italy
[7] Inst Paoli Calmettes, Cell Therapy Unit, Marseille, France
[8] Aix Marseille Univ, Marseille, France
[9] Aix Marseille Univ, Inst Paoli Calmettes, Ctr Rech Cancerol Marseille, INSERM, Marseille, France
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷 / 12期
关键词：
BRENTUXIMAB VEDOTIN;
D O I：
10.1038/bmt.2016.257
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1644 / 1646
页数：3
相关论文
共 50 条
  • [21] Prognostic factors affecting long-term outcome in patients with Hodgkin lymphoma who relapse after autologous stem cell transplantation
    Constans, M
    Sureda, A
    Arranz, R
    Caballero, MD
    Lahuerta, JJ
    Hernández-Boluda, J
    Vidal, M
    García-Laraña, J
    Rifón, J
    Ribera, J
    Fernández-Abellán, P
    Moraleda, J
    Bernal, M
    Mateos, M
    Martín-Mateos, M
    Córdoba, R
    García-Conde, J
    Sierra, J
    Conde, E
    BONE MARROW TRANSPLANTATION, 2004, 33 : S6 - S7
  • [22] Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry
    Freytes, CO
    Loberiza, FR
    Rizzo, JD
    Bashey, A
    Bredeson, CN
    Cairo, MS
    Gale, RP
    Horowitz, MM
    Klumpp, TR
    Martino, R
    McCarthy, PPL
    Molina, A
    Pavlovsky, S
    Pecora, AL
    Serna, DS
    Tsai, T
    Zhang, MJ
    Vose, JM
    Lazarus, HM
    van Besien, K
    BLOOD, 2004, 104 (12) : 3797 - 3803
  • [23] Cytomegalovirus replication after allogeneic stem cell transplantation is associated with a decreased relapse risk in patients with lymphoma
    Mariotti, J.
    Maura, F.
    Spina, F.
    Roncari, L.
    Dodero, A.
    Farina, L.
    Montefusco, V.
    Sarina, B.
    Patriarca, F.
    Corradini, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S251 - S253
  • [24] OUTCOMES OF MANTLE CELL LYMPHOMA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Costa, R.
    Palmer, J.
    Shen, Y.
    Paris, T.
    Popplewell, L.
    Kogut, N. M.
    Forman, S. J.
    Nademanee, A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S330 - S330
  • [25] Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) after Treatment with Nivolumab for Relapsed/Refractory Hodgkin Lymphoma
    Armand, Philippe
    Zinzani, Pier Luigi
    Collins, Graham P.
    Cohen, Jonathon B.
    Halwani, Ahmad S.
    Carlo-Stella, Carmelo
    Millenson, Michael M.
    Provencio, Mariano
    Domenech, Eva Domingo
    Roth, Lisa Giulino
    Castagna, Luca
    Kato, Kazunobu
    McKiver, Mihaela Popa
    Sumbul, Anne
    Zhu, Lili
    Santoro, Armando
    BLOOD, 2016, 128 (22)
  • [26] Outcome and Prognostic Factors for Patients Who Relapse after Allogeneic Hematopoietic. Stem Cell Transplantation
    Thanarajasingam, Gita
    Kim, Haesook T.
    Cutler, Corey
    Ho, Vincent T.
    Koreth, John
    Alyea, Edwin P.
    Antin, Joseph H.
    Soiffer, Robert J.
    Armand, Philippe
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (12) : 1713 - 1718
  • [27] Outcome of Hodgkin's lymphoma (HL) patients relapsing after allogeneic stem cell transplantation (ALLO)
    Castagna, L.
    Bramanti, S.
    Giordano, L.
    Sarina, B.
    Mauro, E.
    Morabito, L.
    Balzarotti, M.
    Anastasia, A.
    Stella, C. Carlo
    Brusamolino, E.
    Santoro, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S419 - S419
  • [28] Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
    A Bacigalupo
    Leukemia, 2003, 17 : 1722 - 1722
  • [29] Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
    Olavarria, E
    Ottmann, OG
    Deininger, M
    Clark, RE
    Bandini, G
    Byrne, J
    Lipton, J
    Vitek, A
    Michallet, M
    Siegert, W
    Ullmann, A
    Wassmann, B
    Niederwieser, D
    Fischer, T
    LEUKEMIA, 2003, 17 (09) : 1707 - 1712
  • [30] Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
    E Olavarria
    O G Ottmann
    M Deininger
    R E Clark
    G Bandini
    J Byrne
    J Lipton
    A Vitek
    M Michallet
    W Siegert
    A Ullmann
    B Wassmann
    D Niederwieser
    T Fischer
    Leukemia, 2003, 17 : 1707 - 1712
12345